
Congress trades
Express Scripts Holding Company (ESRX)
NASDAQ · Healthcare · 54 congress trades · last filed 5 years agono longer trading under this ticker
About Express Scripts Holding Company
from the company's filings and listing- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Medical - Pharmaceuticals
- Chief executive
- -
- Employees
- -
- Listed since
- Jun 9, 1992
- Market value
- -
- Price to earnings
- 11.9
- Earnings per share
- $7.79
- Dividend yield
- -
Congress trades in ESRX
20 disclosures of 54 on record · median 27d of the 45 allowed| Member | Type | Action | Amount disclosed | Since the trade | Trade date | Disclosed | Delay |
|---|---|---|---|---|---|---|---|
| Thomas R. SuozziFiled late | Stock | Sale | $15,001 - $50,000 | +30.3%S&P +8.6% · vs S&P 500 +21.7% | Jan 5, 2017 | Sep 23, 2021 | 1722d |
| Gilbert Ray Cisneros, Jr. | Stock | Sale | $1,001 - $15,000 | n/a | Feb 6, 2019 | Mar 8, 2019 | 30d |
| Gary J. PalmerJoint | Stock | Sale | $1,001 - $15,000 | -3.8%S&P -14.7% · vs S&P 500 +10.9% | Oct 5, 2018 | Nov 7, 2018 | 33d |
| Lois Frankel | Stock | Sale | $1,001 - $15,000 | -3.2%S&P -15.9% · vs S&P 500 +12.7% | Oct 3, 2018 | Oct 30, 2018 | 27d |
| Gary J. PalmerJointFiled late | Stock | Purchase | $1,001 - $15,000 | +13.1%S&P -12.0% · vs S&P 500 +25.2% | Jul 12, 2018 | Sep 29, 2018 | 79d |
| Gary J. PalmerSpouseFiled late | Stock | Purchase | $1,001 - $15,000 | +40.1%S&P +4.4% · vs S&P 500 +35.8% | Apr 4, 2017 | Sep 29, 2018 | 543d |
| Gary J. PalmerFiled late | Stock | Purchase | $1,001 - $15,000 | +20.2%S&P -13.8% · vs S&P 500 +33.9% | Aug 6, 2018 | Sep 29, 2018 | 54d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +35.5%S&P -8.0% · vs S&P 500 +43.5% | May 8, 2018 | Jun 8, 2018 | 31d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +33.8%S&P -5.8% · vs S&P 500 +39.6% | Apr 3, 2018 | May 10, 2018 | 37d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +17.4%S&P -10.5% · vs S&P 500 +27.9% | Feb 27, 2018 | Mar 9, 2018 | 10d |
| Lois Frankel | Stock | Purchase | $1,001 - $15,000 | +14.9%S&P -10.4% · vs S&P 500 +25.3% | Jan 10, 2018 | Jan 23, 2018 | 13d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +50.2%S&P -5.6% · vs S&P 500 +55.8% | Nov 27, 2017 | Dec 12, 2017 | 15d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +50.3%S&P -6.5% · vs S&P 500 +56.8% | Nov 28, 2017 | Dec 12, 2017 | 14d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +41.7%S&P -7.3% · vs S&P 500 +48.9% | Nov 30, 2017 | Dec 12, 2017 | 12d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +48.5%S&P -4.7% · vs S&P 500 +53.1% | Oct 27, 2017 | Nov 9, 2017 | 13d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +56.9%S&P -4.2% · vs S&P 500 +61.1% | Oct 24, 2017 | Nov 9, 2017 | 16d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +47.8%S&P -1.3% · vs S&P 500 +49.1% | Sep 25, 2017 | Oct 10, 2017 | 15d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +53.0%S&P +1.1% · vs S&P 500 +51.9% | Aug 21, 2017 | Sep 8, 2017 | 18d |
| Ro Khanna | Stock | Purchase | $1,001 - $15,000 | +45.0%S&P +1.2% · vs S&P 500 +43.8% | Jul 5, 2017 | Aug 10, 2017 | 36d |
| Ro Khanna | Stock | Sale | $1,001 - $15,000 | +47.4%S&P 0.0% · vs S&P 500 +47.4% | Jul 18, 2017 | Aug 10, 2017 | 23d |
Since the trade: the stock's move from the trade date to the latest close we hold, as of Sep 10, 2026, an estimate, with the S&P 500 over the same window and the difference against it. The figures describe the stock after the trade, not the member's result: the filing carries a band, not a fill, and a sale keeps the same sign, so a positive figure after a sale means the stock kept rising. An option row carries the underlying stock's move. A row marked n/a has no market price. Not investment advice.
Questions
Which members of Congress have traded ESRX?
Thomas R. Suozzi, Gilbert Ray Cisneros, Jr., Gary J. Palmer, Lois Frankel, Ro Khanna disclosed ESRX transactions in the filings shown here.
How quickly are ESRX trades disclosed?
Congressional disclosures took a median of 27 days, against the 45 the STOCK Act allows.
How to read a STOCK Act filing
WHAT THE FILING ACTUALLY SAYS
Congress rows disclose a value range rather than an exact amount, and the STOCK Act allows up to 45 days to report. Full sourcing and the limits of this data are on the methodology page. A filing is a record of a transaction, not a signal, and nothing here is investment advice.
Data as of Sep 10, 2026.
